<scp>GLP</scp> ‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity
Article 2025 en
Authors
TB
Tommaso Bucci
UA
Uazman Alam
GF
Grégoire Fauchier
Abstract
1 min read
The use of GLP-1RAs was associated with lower rates of cardiovascular events than no use in patients with MUHO. Similar but non-statistically significant trends were seen in patients with MHO.
Discussion(0)
No comments yet. Be the first to comment.